Skip to content
healthcare.dev
Get a free key

Hydroxyzine Pamoate

NDC 76420-922, Hydroxyzine Pamoate, capsule, from Asclemed USA, Inc..

Product NDC
76420-922
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA088488
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-922 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROXYZINE PAMOATE100 mg/1

Pharmacologic classes

Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]

Package NDCNDC-11Package
76420-922-0176420092201100 CAPSULE in 1 BOTTLE (76420-922-01)
76420-922-307642009223030 CAPSULE in 1 BOTTLE (76420-922-30)
76420-922-607642009226060 CAPSULE in 1 BOTTLE (76420-922-60)
76420-922-907642009229090 CAPSULE in 1 BOTTLE (76420-922-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/82187031-779e-47bc-943c-eb1a1ef30a7a

Use it

Look up 76420-922 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-922 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-922. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.